FDA regulatory submission support for medical devices including 510(k), De Novo, and PMA strategy.
US FDA Regulatory Submission Services
Bioexcel supports manufacturers in designing and executing FDA regulatory pathways across 510(k), De Novo, PMA, and IDE submissions. Our approach integrates regulatory intelligence, clinical evidence strategy, and structured submission architecture to minimize deficiencies and accelerate FDA review cycles.
Regulatory Framework Alignment
Our submissions align with:
- 21 CFR Part 807 (510(k))
- 21 CFR Part 814 (PMA)
- 21 CFR Part 812 (IDE)
- 21 CFR Part 820 (QMSR transition readiness)
- FDA Guidance Documents & Review Memoranda
- Human Factors Engineering Guidance
- Cybersecurity & Software Guidance
We design submissions anticipating FDA review expectations — not reacting to them.
Submission Development & Execution
- 510(k) preparation (Traditional / Special / Abbreviated)
- De Novo classification requests
- PMA submission strategy & module preparation
- Clinical evidence mapping & gap assessment
- Human factors & usability documentation
- Risk management alignment (ISO 14971)
- Software documentation (per FDA guidance)
- FDA deficiency response management
FDA Regulatory Capabilities
Strategic Pathway Determination
- Device classification & product code analysis
- Predicate device identification & substantial equivalence strategy
- Regulatory pathway determination (510(k), De Novo, PMA, HDE)
- Pre-Submission (Q-Sub) & FDA interaction strategy
- IDE strategy for significant risk devices
Beyond Submission Preparation
We structure FDA submissions with:
- Clear claim-to-evidence traceability
- Deficiency mitigation planning
- Structured clinical justification
- Risk-based argumentation
- Pre-emptive reviewer concern identification
Our objective: reduce review cycles, avoid major deficiency letters, and strengthen clearance probability.
US FDA Regulatory Strategy & Submissions
Structured Pathways to 510(k), De Novo & PMA Approval. Regulatory strategy, submission preparation, and FDA-facing execution for medical devices and IVDs. From classification to clearance — engineered for compliance, defensibility, and review efficiency.
Frequently Asked Questions (FAQ)
Regulatory
US FDA Medical Device Regulatory Submissions
FDA regulatory submission support for medical devices including 510(k), De Novo, and PMA strategy.